common.study.topics.clinical

Circulating Tumor DNA Exposure in Peripheral Blood

common.study.values.description

“Circulating Tumor DNA Exposure in Peripheral Blood”

This is a prospective, multi-center, blinded feasibility study. The objective of this study is to test the feasibility of the detection of tumor DNA of a variety of tumors in peripheral blood using a novel process for the detection of circulating tumor DNA (ctDNA).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

common.study.methods.no-methods

participant.views.study.view.additional

participant.views.study.view.scientific-title

Circulating Tumor DNA Exposure in Peripheral Blood Using a Novel Process: A Feasibility Study

common.study.values.clinical-trial-id

NCT03517332

participant.views.study.view.id

lejxyb